skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 85,145  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Breast Cancer remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
2022-RA-1561-ESGO GATA3 expression is significantly correlated with oestrogen receptor expression, but not clinico-pathological features in breast cancer
Material Type:
Article
Add to My Research

2022-RA-1561-ESGO GATA3 expression is significantly correlated with oestrogen receptor expression, but not clinico-pathological features in breast cancer

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A215-A215 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2022-ESGO.462

Full text available

2
Breast Cancer Statistics, 2022
Material Type:
Article
Add to My Research

Breast Cancer Statistics, 2022

CA: a cancer journal for clinicians, 2022-11, Vol.72 (6), p.524-541 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Nov/Dec 2022 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21754

Full text available

3
The relationship between breast and axillary pathologic complete response in women receiving neoadjuvant chemotherapy for breast cancer
Material Type:
Article
Add to My Research

The relationship between breast and axillary pathologic complete response in women receiving neoadjuvant chemotherapy for breast cancer

Canadian Journal of Surgery, 2021-12, Vol.64, p.S145-S146 [Peer Reviewed Journal]

Copyright Joule Inc Dec 2021 ;ISSN: 0008-428X ;EISSN: 1488-2310

Full text available

4
WOMEN'S HEALTH BELIEFS AND INTENTIONS TO USE CHEMOPREVENTION FOR BREAST CANCER
Material Type:
Article
Add to My Research

WOMEN'S HEALTH BELIEFS AND INTENTIONS TO USE CHEMOPREVENTION FOR BREAST CANCER

Oncology nursing forum, 2023-03, Vol.50 (2), p.C198-C198 [Peer Reviewed Journal]

Copyright Oncology Nursing Society Mar 2023 ;ISSN: 0190-535X ;EISSN: 1538-0688

Full text available

5
241 Palbociclib in the daily clinical use: real experience in metastatic breast cancer in our institution
Material Type:
Article
Add to My Research

241 Palbociclib in the daily clinical use: real experience in metastatic breast cancer in our institution

International journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A98-A99 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-IGCS.207

Full text available

6
EP026/#1090 Breast cancer in young women
Material Type:
Article
Add to My Research

EP026/#1090 Breast cancer in young women

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A59-A60 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2022-igcs.117

Full text available

7
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
Material Type:
Article
Add to My Research

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

The lancet oncology, 2018-10, Vol.19 (10), p.1385-1393 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 2018 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(18)30380-2 ;PMID: 30196031

Full text available

8
Inverse probability weighting
Material Type:
Article
Add to My Research

Inverse probability weighting

BMJ (Online), 2016-01, Vol.352, p.i189-i189 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i189 ;PMID: 26773001

Full text available

9
The people behind the numbers: women with breast cancer
Material Type:
Article
Add to My Research

The people behind the numbers: women with breast cancer

The lancet oncology, 2023-01, Vol.24 (1), p.17-18 [Peer Reviewed Journal]

2023 Elsevier Ltd ;2023. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(22)00678-7

Full text available

10
Epithelial ovarian cancer
Material Type:
Article
Add to My Research

Epithelial ovarian cancer

The Lancet (British edition), 2019-03, Vol.393 (10177), p.1240-1253 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32552-2 ;PMID: 30910306

Full text available

11
Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review
Material Type:
Article
Add to My Research

Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

Cancers, 2021-08, Vol.13 (17), p.4287 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers13174287 ;PMID: 34503097

Full text available

12
EP686 Breast cancer and pregnancy -our experience and literature data review
Material Type:
Article
Add to My Research

EP686 Breast cancer and pregnancy -our experience and literature data review

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A393-A393 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-ESGO.740

Full text available

13
S2479 Breast Cancer With Synchronous Endoluminal Upper and Lower GI Metastases
Material Type:
Article
Add to My Research

S2479 Breast Cancer With Synchronous Endoluminal Upper and Lower GI Metastases

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e1651-e1651 [Peer Reviewed Journal]

2022 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000866556.69582.63

Full text available

14
Expanding mammography screening for women aged 40–80 years: evidence from a modeling approach using real-world data
Material Type:
Article
Add to My Research

Expanding mammography screening for women aged 40–80 years: evidence from a modeling approach using real-world data

Scientific reports, 2023-09, Vol.13 (1), p.16229-16229, Article 16229 [Peer Reviewed Journal]

Springer Nature Limited 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Springer Nature Limited 2023 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-023-42820-9 ;PMID: 37758770

Full text available

15
Differences in Breast Cancer Survival by Molecular Subtypes in the United States
Material Type:
Article
Add to My Research

Differences in Breast Cancer Survival by Molecular Subtypes in the United States

Cancer epidemiology, biomarkers & prevention, 2018-06, Vol.27 (6), p.619-626 [Peer Reviewed Journal]

2018 American Association for Cancer Research. ;Copyright American Association for Cancer Research, Inc. Jun 2018 ;ISSN: 1055-9965 ;EISSN: 1538-7755 ;DOI: 10.1158/1055-9965.epi-17-0627 ;PMID: 29593010

Full text available

16
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial
Material Type:
Article
Add to My Research

Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial

The lancet oncology, 2019-03, Vol.20 (3), p.352-360 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 2019 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(18)30813-1 ;PMID: 30711522

Full text available

17
Levels of Visceral and Subcutaneous Abdominal Adipose Tissue and Postmenopausal Breast Cancer Risk
Material Type:
Article
Add to My Research

Levels of Visceral and Subcutaneous Abdominal Adipose Tissue and Postmenopausal Breast Cancer Risk

Obesity (Silver Spring, Md.), 2022-11, Vol.30, p.35-35 [Peer Reviewed Journal]

Copyright Blackwell Publishing Ltd. Nov 2022 ;ISSN: 1930-7381 ;EISSN: 1930-739X

Full text available

18
Surrogate endpoints in breast cancer screening trials – Authors' reply
Material Type:
Article
Add to My Research

Surrogate endpoints in breast cancer screening trials – Authors' reply

The lancet oncology, 2022-08, Vol.23 (8), p.e361-e361 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(22)00396-5

Full text available

19
International evaluation of an AI system for breast cancer screening
Material Type:
Article
Add to My Research

International evaluation of an AI system for breast cancer screening

Nature (London), 2020-01, Vol.577 (7788), p.89-94 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1799-6 ;PMID: 31894144

Full text available

20
799 Breast cancer in BRCA1 and BRCA2 mutations carriers, clinicopathological features
Material Type:
Article
Add to My Research

799 Breast cancer in BRCA1 and BRCA2 mutations carriers, clinicopathological features

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A168-A168 [Peer Reviewed Journal]

IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-ESGO.282

Full text available

Results 1 - 20 of 85,145  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1978  (21)
  2. 1978 To 1988  (144)
  3. 1989 To 1999  (2,008)
  4. 2000 To 2011  (20,855)
  5. After 2011  (62,146)
  6. More options open sub menu

Subject 

  1. Womens Health  (83,052)
  2. Mammography  (27,268)
  3. Science & Technology  (16,941)
  4. Medical Research  (15,752)
  5. Cancer Therapies  (15,530)
  6. Life Sciences & Biomedicine  (15,478)
  7. Studies  (13,272)
  8. Humans  (12,166)
  9. Female  (11,626)
  10. Hormone Replacement Therapy  (10,642)
  11. Oncology  (10,047)
  12. Chemotherapy  (9,626)
  13. Patients  (8,690)
  14. Medical Screening  (8,392)
  15. Cancer  (7,910)
  16. Tumors  (7,180)
  17. Middle Aged  (6,596)
  18. Mortality  (6,380)
  19. Health Risk Assessment  (5,652)
  20. More options open sub menu

Language 

  1. English  (84,954)
  2. Japanese  (1,267)
  3. Spanish  (192)
  4. Portuguese  (82)
  5. Urdu  (60)
  6. French  (36)
  7. Turkish  (34)
  8. Polish  (31)
  9. Chinese  (30)
  10. German  (18)
  11. Norwegian  (14)
  12. Russian  (4)
  13. Italian  (4)
  14. Ndongo  (4)
  15. Czech  (2)
  16. Arabic  (2)
  17. Kinyarwanda  (2)
  18. Hindi  (2)
  19. Swedish  (2)
  20. Azerbaijani  (1)
  21. More options open sub menu

Searching Remote Databases, Please Wait